Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.

Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.

Becton, Dickinson and Company (NYSE:BDX) authorized to pursue a plan to separate BD’s Biosciences and Diagnostic Solutions ...

Becton Dickinson plans to separate its Biosciences and Diagnostic Solutions unit, aiming for completion ... In July, Embecta, a manufacturer of disposable insulin pen needles and syringes, said ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

Each Soliqua 100/33 pen contains 3 milliliters (mL) of solution, with 300 units of insulin and 99 micrograms (mcg) of lixisenatide per pen. (This is 100 units of insulin and 33 mcg of lixisenatide ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...

Humulin R is available in two strengths: U-100, which contains 100 units of insulin ... that you’ll use with insulin syringes 3-mL disposable, prefilled injection pens called a KwikPens Note ...

Medtronic's diabetes care unit, the most impressive in terms of sales growth, is gaining prominence and still has plenty of room to grow. Medtronic develops innovative insulin pumps and pens ...

Now, not only do I not care if people know I have diabetes, but sometimes, at business dinners, I pull out my insulin pens, screw in the needle, and push the required units into my belly right ...